KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia paxalisib Phase II interim data, page-22

  1. onesurfed
    2,071 Posts.
    lightbulb Created with Sketch. 443
    clock Created with Sketch.
    09/04/20
    09:00
    Post #: 43963899
    Jazza- Looks like we're both wrong. James just said the AGILE trial will involve unmethylated MGMT-promoter status disease and that OS will the the primary endpoint. Considering the data just released was for similar unmeth population, looking good for the AGILE trial. Just missed my chance to ask a question due to typing this
    KZA Price at posting: 44.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.